Stanford Cancer Institute — Palo Alto, California

Stanford Cancer Institute is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute has participated in 80 clinical trials with 36 currently active.

Therapeutic areas: Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer.

Sponsors: Gynecologic Oncology Group, Gilead Sciences, Allogene Therapeutics.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute?

Stanford Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute conducted?

Stanford Cancer Institute has 80 clinical trials on record, with 36 currently active. Their work covers Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer.

Is Stanford Cancer Institute accredited by Crixeo Health?

Stanford Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.